# PNXP (Pineapple Express Cannabis Company) - SEC EDGAR Financial Statements

> Pineapple Express Cannabis Company reported $0 in revenue and a net loss of $653K for the trailing twelve months ended October 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/PNXP
- Markdown: https://convexityos.com/fundamentals/PNXP.md
- SEC CIK: 0001710495
- Reporting currency: USD
- Latest filing period: October 31, 2025
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001710495&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -100.0% YoY |
| Operating Income | TTM | -$336K | Operating profit |
| Net Income | TTM | -$653K | GAAP bottom line |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Oct 31, 2025 | $0 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $16K | $0 | $5.4K | $7.8K | $30K | $43K | $14K |
| Cost of Revenue | -- | -- | -- | -- | $5.6K | $7.8K | $0 |
| **Gross Profit** | -- | -- | $5.4K | $7.8K | $25K | $35K | $14K |
| Total Operating Expenses | $33K | $59K | $22K | $54K | $44K | -$37K | -$18K |
| **Operating Income** | -$17K | -$59K | -$16K | -$46K | -$20K | -$2.3K | $32K |
| **EBITDA** | -- | -$59K | -$14K | -$33K | -$4.3K | -$163 | $36K |
| Income Before Tax | -$31K | -$59K | -$44K | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$31K | -$59K | -$44K | -$46K | -$20K | -$2.3K | -$4.0K |
| Basic EPS | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | -- | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 19.8M | 20.3M | 19.0M | 3.7M | -- | -- | -- |
| Diluted Shares Outstanding | -- | 20.3M | 19.0M | -- | 3.1M | 2.8M | 2.8M |

### Income Statement (Quarterly)

| Line Item | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $4.3K | $9.9K | $2.0K | -- |
| **Gross Profit** | -- | -- | -- | -- | $4.3K | $9.9K | $2.0K | -- |
| Total Operating Expenses | -$111K | $246K | $185K | $16K | $5.6K | $5.6K | $5.6K | $8.4K |
| **Operating Income** | $111K | -$246K | -$185K | -$16K | -$1.2K | $4.3K | -$3.6K | -$8.4K |
| **EBITDA** | -- | -- | -- | -- | -$1.1K | $4.4K | -$3.5K | -$8.3K |
| Interest Expense | $99K | $101K | $128K | -- | $0 | $0 | $0 | -- |
| Income Before Tax | -- | -- | -- | -$31K | -$1.2K | $4.3K | -$3.6K | -$994K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | $20K | $17K | -$659K | -$31K | -$1.2K | $4.3K | -$3.6K | -$994K |
| Basic EPS | -$0.01 | $0.00 | -$0.03 | -- | $0.00 | $0.00 | $0.00 | -- |
| **Diluted EPS** | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 | -- |
| Basic Shares Outstanding | 39.2M | 30.4M | 21.9M | -- | 19.8M | 19.8M | 19.8M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 19.8M | 19.8M | 19.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $30 | -- | $5.3K | $3.5K | $511 | $696 | $626 |
| **Cash & Short-Term Investments** | $0 | $30 | -- | $5.3K | $3.5K | $511 | $696 | $626 |
| **Total Current Assets** | $0 | $30 | $0 | $5.3K | $6.2K | $16K | $696 | $1.1K |
| Property, Plant & Equipment, Net | $0 | $1.8K | $2.3K | $13K | $26K | $11K | $0 | $3.7K |
| Long-Term Investments | -- | -- | -- | -- | -$12K | -$12K | $0 | -- |
| **Total Non-Current Assets** | $0 | $1.8K | $2.3K | $13K | $26K | $11K | $0 | $4.8K |
| **Total Assets** | $0 | $1.9K | $2.3K | $18K | $32K | $27K | $696 | $3.7K |
| Accounts Payable | -- | $18K | $1.3K | $4.6K | -- | $0 | $1.1K | $0 |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $0 | $2.8K |
| Other Current Liabilities | -- | -- | $45K | $73K | -- | -- | $0 | $0 |
| **Total Current Liabilities** | $2.1K | $18K | $547K | $77K | $48K | $37K | $9.8K | $10K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $48K | $37K | $9.8K | $10K |
| **Total Liabilities** | $2.1K | $18K | $547K | $77K | $48K | $27K | $696 | $4.8K |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $15K | $12K | -- |
| Common Stock | $20K | $21K | $19K | $3.7K | $3.6K | $0 | $0 | $0 |
| Retained Earnings | -$674K | -$642K | -$583K | -$80K | $34K | -$15K | -$12K | -$8.5K |
| **Total Stockholders' Equity** | -- | -$16K | -$544K | -$59K | -$16K | -$9.0K | -$9.1K | -$5.7K |
| Total Equity | -$2.1K | -$16K | -$544K | -$59K | -$16K | -$9.0K | -$9.1K | -$5.7K |

### Balance Sheet (Quarterly)

| Line Item | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $0 | $0 | $0 | $1.0K | $0 | $0 | $30 |
| **Cash & Short-Term Investments** | $0 | $0 | $0 | $0 | $1.0K | $0 | $0 | $30 |
| Accounts Receivable, Net | -- | -- | -- | -- | $14K | $9.9K | $2.0K | -- |
| **Total Current Assets** | $0 | $0 | $0 | $0 | $15K | $9.9K | $2.0K | $30 |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $1.5K | $1.6K | $1.7K | $1.8K |
| Intangible Assets | -- | -- | -- | -- | $3.00M | $3.00M | -- | -- |
| **Total Non-Current Assets** | $190K | $190K | $190K | $0 | $1.5K | $1.6K | $1.7K | $1.8K |
| **Total Assets** | $190K | $190K | $190K | $0 | $3.02M | $3.01M | $5.00M | $1.9K |
| Accounts Payable | -- | -- | -- | -- | $20K | $15K | $12K | $18K |
| Other Current Liabilities | -- | -- | -- | -- | $2.97M | $2.97M | -- | -- |
| **Total Current Liabilities** | $8.34M | $8.37M | $8.40M | $2.1K | $2.99M | $2.98M | $12K | $18K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $4.97M | $0 |
| **Total Liabilities** | $8.34M | $8.37M | $8.40M | $2.1K | $2.99M | $2.98M | $4.98M | $18K |
| Common Stock | $43K | $38K | $25K | $20K | $20K | $20K | $20K | $21K |
| Retained Earnings | -$1.30M | -$1.32M | -$1.33M | -$674K | -$924K | -$923K | -$927K | -$642K |
| **Total Stockholders' Equity** | -- | -- | -- | -- | $29K | $30K | $25K | -$16K |
| Total Equity | -$8.15M | -$8.18M | -$8.21M | -$2.1K | $29K | $30K | $25K | -$16K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$31K | -$59K | -$44K | -$46K | -$20K | -$2.3K | -$4.0K |
| Depreciation & Amortization | -- | $460 | $2.8K | $13K | $15K | $2.2K | $4.6K |
| Stock-Based Compensation | -- | -- | $70 | -- | -- | -- | -- |
| Change in Receivables | -$14K | $0 | -- | -- | -- | -- | -- |
| Change in Payables | -- | $16K | -$3.3K | $4.6K | $0 | -$1.1K | $1.1K |
| **Operating Cash Flow** | -$45K | $30 | -$17K | -$26K | $1.4K | -$9.7K | -$610 |
| Capital Expenditure | -- | -- | -- | -- | $30K | $13K | -- |
| **Free Cash Flow** | -- | -- | -- | -- | $32K | $3.4K | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -$70 |
| Purchases of Investments | -- | -- | -- | -- | $0 | -$12K | -- |
| **Investing Cash Flow** | -- | -- | -- | -- | -$30K | -$13K | -$920 |
| Common Stock Issued | $45K | $0 | -- | $3.1K | $13K | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -$630 | -$120 | -- |
| **Financing Cash Flow** | $45K | $0 | $11K | $27K | $32K | $23K | $1.6K |
| **Net Change in Cash** | -$30 | $30 | -$5.3K | $1.7K | $3.0K | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $20K | $17K | -$320K | -$31K | -$1.2K | $4.3K | -$3.6K | -$994K |
| Depreciation & Amortization | -- | -- | -- | -- | $115 | $115 | $115 | $115 |
| Change in Receivables | $0 | $0 | $0 | $0 | -$4.3K | -$7.9K | -$2.0K | -- |
| Change in Payables | -- | -- | -- | -- | $5.4K | $3.5K | -$6.3K | $2.1K |
| **Operating Cash Flow** | $1.8K | $0 | $937K | -$33K | -$19 | $0 | -$12K | $36K |
| **Investing Cash Flow** | $0 | $0 | -$190K | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | -$1.8K | $0 | -$747K | $33K | $430 | $0 | $12K | -$36K |
| **Net Change in Cash** | $0 | $0 | $0 | -$411 | $411 | $0 | -$30 | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | 100.0% | 100.0% | 81.5% | 81.8% | 100.0% |
| **Operating Margin** | -104.3% | -- | -303.0% | -594.6% | -64.5% | -5.4% | 229.2% |
| **Net Profit Margin** | -192.7% | -- | -825.3% | -594.6% | -64.5% | -5.4% | -29.2% |
| Return on Assets (ROA) | -- | -3181.7% | -1932.3% | -253.1% | -60.4% | -8.5% | -577.6% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.07x | 0.13x | 0.45x | 0.07x |
| Quick Ratio | 0.00x | 0.00x | -- | 0.07x | 0.07x | 0.01x | 0.07x |
| **Revenue Growth (YoY)** | -- | -100.0% | -30.5% | -74.4% | -29.2% | +210.8% | -- |
| Gross Profit Growth (YoY) | -- | -- | -30.5% | -68.5% | -29.5% | +154.2% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -107.4% | -- |
| Operating Cash Flow Growth (YoY) | -150203.3% | -- | -- | -1911.3% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | +826.5% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -10352.0% | -1392.8% | -104.3% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -15569.3% | -4835.5% | -192.7% | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -3490.2% | -3346.7% | -1516.2% | -- |
| Return on Assets (ROA) | -343.6% | -355.0% | -361.5% | -- | -33.0% | -33.1% | -7.7% | -10843.5% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.17x | 0.00x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.17x | 0.00x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -100.0% | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -5839.1% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | +288.1% | -- | -- | -- | -99.3% | -102.0% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -191.4% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
